From The Editor-In-Chief
Emerging insights into epigenetic abnormalities in cancer cells may lead to better cancer outcomes.
by William G. Nelson, MD, PhD
Getting Help to Avoid Financial Distress | Cryoablation May Be a Treatment Option for Some Patients | Makers of E-Cigarettes Tout Role in Smoking Cessation | More Options to Prevent Blood Clots in High-Risk Cancer Patients | New Guidelines for Radiation Therapy in Pancreatic Cancer | Managing Opioid-Related Constipation | What’s Next
YOUR CANCER GUIDE
Patients with metastatic disease need to carefully consider risks and benefits of therapies within the context of their goals.
by Hester Hill Schnipper
CAREGIVING WITH CONFIDENCE
When families work together to provide care for a loved one, communicating can become a challenge.
by Ashley Jones
Cancer outcomes are changing for the better, but advances are not affecting all patients equally.
by Brian Rivers, PhD
A gene-editing tool called CRISPR holds promise for treating cancer. What does the new technology mean for patients?
by Stephen Ornes
Mark Good uses every avenue to spread the news about prostate cancer.
by Lindsey Konkel
Pancreatic cancer remains a difficult disease to treat and is expected to be the second leading cause of U.S. cancer-related deaths by 2030. Researchers hope clinical trials and insights into the genetics of the disease will reverse the trend.
by Kendall K. Morgan
Advocacy in Action
Two mothers, each with a son who died of brain cancer, worked together to increase awareness and acceptance of tumor tissue donation.
by Esther Landhuis
Go With Your Gut | The ABCs of CBD
Science writer Charles Graeber describes how a shift in researchers’ understanding of immune function and cancer is leading to effective treatments.
by Marci A. Landsmann
Experts offer advice on getting involved with patient advocacy, expressing feelings to loved ones, and hospice care.
A mother whose son was diagnosed with Burkitt leukemia works to improve access to mental health services for teenagers.
by Elizabeth Rosto Sitko
Readers share snapshots of their lives today.
This year’s AACR Annual Meeting features the latest advances in basic, translational and clinical cancer research. The more than 13,000 attendees at the virtual event represent more than 70 countries.
by Kevin McLaughlin
The immune systems of people with blood cancer respond differently to infection with the coronavirus than the immune systems of people without cancer or with solid tumors.
by Kate Yandell
In recent months, drugmakers have announced they are withdrawing indications for four immune checkpoint inhibitors in consultation with the Food and Drug Administration. What does this mean for patients who are taking these drugs?
by Anna Goshua
After her husband’s diagnosis with metastatic cancer, Miriam Díaz-Gilbert made it her goal to keep him moving.
by Miriam Díaz-Gilbert
For the second consecutive year, this year’s AACR Annual Meeting will take place in a virtual format. Read this user's guide to the meeting.
Since the founding of the American Association for Cancer Research more than 100 years ago, women have played many pivotal roles.
The AACR collaborated with the Food and Drug Administration to examine under-representation of African Americans in multiple myeloma clinical trials.
Learning Medicare’s ABCDs
donate to the AACR